Sparks Lauren M, Redman Leanne M, Conley Kevin E, Harper Mary-Ellen, Yi Fanchao, Hodges Andrew, Eroshkin Alexey, Costford Sheila R, Gabriel Meghan E, Shook Cherie, Cornnell Heather H, Ravussin Eric, Smith Steven R
Translational Research Institute for Metabolism and Diabetes, Florida Hospital, Orlando, Florida 32804.
Clinical and Molecular Origins of Disease, Sanford Burnham Prebys Medical Discovery Institute, Orlando, Florida 32827.
J Clin Endocrinol Metab. 2017 Jan 1;102(1):111-121. doi: 10.1210/jc.2016-3211.
The effects of caloric restriction (CR) on in vivo muscle mitochondrial function in humans are controversial.
We evaluated muscle mitochondrial function and associated transcriptional profiles in nonobese humans after 12 months of CR.
Individuals from an ancillary study of the CALERIE 2 randomized controlled trial were assessed at baseline and 12 months after a 25% CR or ad libitum (control) diet.
The study was performed at Pennington Biomedical Research Center in Baton Rouge, LA.
Study participants included 51 (34 female subjects, 25 to 50 years of age) healthy nonobese individuals randomized to 1 of 2 groups (CR or control).
This study included 12 months of a 25% CR or ad libitum (control) diet.
In vivo mitochondrial function [maximal ATP synthesis rate (ATPmax), ATPflux/O2 (P/O)] was determined by 31P-magnetic resonance spectroscopy and optical spectroscopy, and body composition was determined by dual-energy X-ray absorptiometry. In a subset of individuals, a muscle biopsy was performed for transcriptional profiling via quantitative reverse transcription polymerase chain reaction and microarrays.
Weight, body mass index (BMI), fat, and fat-free mass (P < 0.001 for all) significantly decreased at month 12 after CR vs control. In vivo ATPmax and P/O were unaffected by 12 months of CR. Targeted transcriptional profiling showed no effects on pathways involved in mitochondrial biogenesis, function, or oxidative stress. A subgroup analysis according to baseline P/O demonstrated that a higher (vs lower) P/O was associated with notable improvements in ATPmax and P/O after CR.
In healthy nonobese humans, CR has no effect on muscle mitochondrial function; however, having a "more coupled" (versus "less coupled") phenotype enables CR-induced improvements in muscle mitochondrial function.
热量限制(CR)对人体体内肌肉线粒体功能的影响存在争议。
我们评估了非肥胖人群在进行12个月热量限制后的肌肉线粒体功能及相关转录谱。
来自热量限制与健康长寿研究(CALERIE 2)随机对照试验辅助研究的个体在基线时以及在接受25%热量限制或随意饮食(对照)12个月后接受评估。
该研究在路易斯安那州巴吞鲁日的彭宁顿生物医学研究中心进行。
研究参与者包括51名(34名女性受试者,年龄在25至50岁之间)健康的非肥胖个体,随机分为2组(热量限制组或对照组)。
本研究包括12个月的25%热量限制或随意饮食(对照)。
通过31P磁共振波谱和光学光谱法测定体内线粒体功能[最大ATP合成速率(ATPmax)、ATP通量/O2(P/O)],通过双能X线吸收法测定身体成分。在一部分个体中,进行肌肉活检以通过定量逆转录聚合酶链反应和微阵列进行转录谱分析。
与对照组相比,热量限制组在第12个月时体重、体重指数(BMI)、脂肪和去脂体重(所有P<0.001)显著降低。12个月的热量限制对体内ATPmax和P/O没有影响。靶向转录谱分析显示对参与线粒体生物发生、功能或氧化应激的途径没有影响。根据基线P/O进行的亚组分析表明,较高(相对于较低)的P/O与热量限制后ATPmax和P/O的显著改善相关。
在健康的非肥胖人群中,热量限制对肌肉线粒体功能没有影响;然而,具有“耦合性更强”(相对于“耦合性更弱”)的表型能够使热量限制引起肌肉线粒体功能的改善。